Skip to main content
Log in

Mitochondrial missile defense

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A relatively obscure immune cell, the eosinophil, has a dramatic way of defending against pathogens. It rapidly ejects mitochondrial DNA, ensnaring bacteria and hastening their demise (pages 949–953).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Eosinophils differentiate under the stimulation of IL-5.

Katie Vicari

References

  1. Rothenberg, M.E. . J. Allergy Clin. Immunol. 113, 11–28; quiz 29 (2004).

    Article  CAS  Google Scholar 

  2. Rothenberg, M.E. & Hogan, S.P. Annu. Rev. Immunol. 24, 147–174 (2006).

    Article  CAS  Google Scholar 

  3. Yousefi, S. et al. Nat. Med. 949–953 (2008).

  4. Jacobsen, E.A., Taranova, A.G., Lee, N.A. & Lee, J.J. J. Allergy Clin. Immunol. 119, 1313–1320 (2007).

    Article  CAS  Google Scholar 

  5. Yang, D. et al. J. Exp. Med. 205, 79–90 (2008).

    Article  CAS  Google Scholar 

  6. Jacobsen, E.A. et al. J. Exp. Med. 205, 699–710 (2008).

    Article  CAS  Google Scholar 

  7. Walsh, E.R. et al. J. Exp. Med. 205, 1285–1292 (2008).

    Article  CAS  Google Scholar 

  8. Mishra, A., Hogan, S.P., Lee, J.J., Foster, P.S. & Rothenberg, M.E. J. Clin. Invest. 103, 1719–1727 (1999).

    Article  CAS  Google Scholar 

  9. Brinkmann, V. et al. Science 303, 1532–1535 (2004).

    Article  CAS  Google Scholar 

  10. Buchanan, J.T. et al. Curr. Biol. 16, 396–400 (2006).

    Article  CAS  Google Scholar 

  11. Fuchs, T.A. et al. J. Cell Biol. 176, 231–241 (2007).

    Article  CAS  Google Scholar 

  12. Gray, M.W., Burger, G. & Lang, B.F. Science 283, 1476–1481 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

M.E.R. is associated with the following companies that are pursuing drugs that target gastrointestinal eosinophils: Ception Therapeutics (consultant and stock owner), Novartis (consultant) and Merck (consultant).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nizet, V., Rothenberg, M. Mitochondrial missile defense. Nat Med 14, 910–912 (2008). https://doi.org/10.1038/nm0908-910

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0908-910

  • Springer Nature America, Inc.

This article is cited by

Navigation